Advertisement
Screener

METAVIA INC. (MTVA) Public Float

2.8 / 5 stars · 68/120 Roast Me

METAVIA INC. Public Float

METAVIA INC. (MTVA) had Public Float of $3.00 million as of 2025-06-30, per its 10-K filed 2026-03-26.

Financial Statements › Notes › Cover Page

dei:EntityPublicFloat · last filed 2026-03-26

  • 2025-06-30: Entity Public Float $3.00M.
  • 2024-06-30: Entity Public Float $13.80M.
  • 2023-06-30: Entity Public Float $6.90M.
  • 2022-06-30: Entity Public Float $7.00M.
Period endEntity Public Float
2025-06-30$3.00M
10-K · filed 2026-03-26
2024-06-30$13.80M
10-K · filed 2025-03-20
2023-06-30$6.90M
10-K · filed 2024-03-28
2022-06-30$7.00M
10-K · filed 2023-03-30
2021-06-30$31.20M
10-K · filed 2022-03-31
2020-06-28$23.40M
10-K · filed 2021-04-15
2019-06-28$10.10M
10-K · filed 2020-03-30
2018-06-29$128.00M
10-K · filed 2019-03-18
2017-06-30$71.30M
10-K · filed 2018-03-20
2016-08-05$30.30M
10-K · filed 2017-03-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92